ND

Nicholas M. Dean

IP Isis Pharmaceuticals: 49 patents #13 of 400Top 4%
EP Excaliard Pharmaceuticals: 6 patents #1 of 13Top 8%
NA Novartis Ag: 3 patents #1,476 of 5,128Top 30%
SF South Alabama Medical Science Foundation: 2 patents #9 of 27Top 35%
ST Sarepta Therapeutics: 2 patents #36 of 64Top 60%
Northwestern University: 1 patents #1,629 of 3,846Top 45%
CI Ciba-Geigy: 1 patents #1,572 of 2,867Top 55%
AT Antisense Therapeutics: 1 patents #9 of 20Top 45%
IP Ionis Pharmaceuticals: 1 patents #89 of 173Top 55%
📍 Cardiff-by-the-Sea, CA: #2 of 51 inventorsTop 4%
🗺 California: #6,949 of 386,348 inventorsTop 2%
Overall (All Time): #47,733 of 4,157,543Top 2%
54
Patents All Time

Issued Patents All Time

Showing 51–54 of 54 patents

Patent #TitleCo-InventorsDate
5801154 Antisense oligonucleotide modulation of multidrug resistance-associated protein Edgardo Baracchini, Jr., C. Frank Bennett 1998-09-01
5744460 Combination for treatment of proliferative diseases Marcel Muller, Thomas Kennith Geiger, Karl-Heinz Altmann, Doriano Fabbro, Brett P. Monia +1 more 1998-04-28
5703054 Oligonucleotide modulation of protein kinase C C. Frank Bennett 1997-12-30
5681747 Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof Russell T. Boggs 1997-10-28